Downregulation of DcR3 sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis

References

• MarquardtJUThorgeirssonSSSnapShot: hepatocellular carcinomaCancer Cell2014254550.e55124735926
   PubMedGoogle Scholar
• SiegelRNaishadhamDJemalACancer statistics, 2012CA Cancer J Clin2012621102922237781
   PubMed Web of Science ®Google Scholar
• LlovetJMBurroughsABruixJHepatocellular carcinomaLancet200336293991907191714667750
   PubMed Web of Science ®Google Scholar
• AvilaMABerasainCSangroBPrietoJNew therapies for hepatocellular carcinomaOncogene200625273866388416799628
   PubMed Web of Science ®Google Scholar
• Del PozoACLopezPManagement of hepatocellular carcinomaClin Liver Dis200711230532117606209
   PubMedGoogle Scholar
• WileySRSchooleyKSmolakPJIdentification and characterization of a new member of the TNF family that induces apoptosisImmunity1995366736828777713
   PubMed Web of Science ®Google Scholar
• PittiRMMarstersSARuppertSDonahueCJMooreAAshkenaziAInduction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine familyJ Biol Chem19962712212687126908663110
   PubMed Web of Science ®Google Scholar
• GolsteinPCell death: TRAIL and its receptorsCurr Biol1997712R750R7539382834
   PubMedGoogle Scholar
• WuGSBurnsTFMcDonaldER3rdKILLER/DR5 is a DNA damage-inducible p53-regulated death receptor geneNat Genet19971721411439326928
   PubMed Web of Science ®Google Scholar
• SheridanJPMarstersSAPittiRMControl of TRAIL-induced apoptosis by a family of signaling and decoy receptorsScience199727753278188219242611
   PubMed Web of Science ®Google Scholar
• KischkelFCLawrenceDAChuntharapaiASchowPKimKJAshkenaziAApo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5Immunity200012661162010894161
   PubMed Web of Science ®Google Scholar
• SprickMRWeigandMARieserEFADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2Immunity200012659960910894160
   PubMed Web of Science ®Google Scholar
• EnariMTalanianRVWongWWNagataSSequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosisNature19963806576727268598910
   PubMedGoogle Scholar
• HallMAClevelandJLClearing the TRAIL for cancer therapyCancer Cell20071214617613431
   PubMedGoogle Scholar
• ZhangJSHerreros-VillanuevaMKoenigADifferential activity of GSK-3 isoforms regulates NF-kappaB and TRAIL- or TNFalpha induced apoptosis in pancreatic cancer cellsCell Death Dis20145e114224675460
   PubMedGoogle Scholar
• OmarHAArafa elSAMaghrabiIAWengJRSensitization of hepatocellular carcinoma cells to Apo2L/TRAIL by a novel Akt/NF- kappaB signalling inhibitorBasic Clin Pharmacol Toxicol2014114646447124401154
   PubMedGoogle Scholar
• TsujiSHosotaniRYoneharaSEndogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinomaInt J Cancer20031061172512794752
   PubMed Web of Science ®Google Scholar
• YuKYKwonBNiJZhaiYEbnerRKwonBSA newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosisJ Biol Chem199927420137331373610318773
   PubMed Web of Science ®Google Scholar
• TakahashiMMiuraYHayashiSTateishiKFukudaKKurosakaMDcR3-TL1A signalling inhibits cytokine-induced proliferation of rheumatoid synovial fibroblastsInt J Mol Med201128342342721537832
   PubMed Web of Science ®Google Scholar
• LiangQLWangBRLiGHDcR3 and survivin are highly expressed in colorectal carcinoma and closely correlated to its clinicopathologic parametersJ Zhejiang Univ Sci B200910967568219735100
   PubMed Web of Science ®Google Scholar
• WangWLiXSunWTriptolide triggers the apoptosis of pancreatic cancer cells via the downregulation of Decoy receptor 3 expressionJ Cancer Res Clin Oncol201213891597160522581262
   PubMedGoogle Scholar
• SungHYWuHGAhnJHParkWYDcr3 inhibit p53-dependent apoptosis in gamma-irradiated lung cancer cellsInt J Radiat Biol201086978079020597837
   PubMed Web of Science ®Google Scholar
• YangDFanXYinPSignificance of decoy receptor 3 (Dcr3) and external-signal regulated kinase 1/2 (Erk1/2) in gastric cancerBMC Immunol2012132822672288
   PubMed Web of Science ®Google Scholar
• ZhouJSongSHeSSilencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivoInt J Mol Med201332365366023846297
   PubMedGoogle Scholar
• WangWZhangMSunWReduction of decoy receptor 3 enhances TRAIL-mediated apoptosis in pancreatic cancerPLoS One2013810e7427224204567
   PubMed Web of Science ®Google Scholar
• WangGZhanYWangHLiWABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic proteinCancer Chemother Pharmacol201269379980522037880
   PubMed Web of Science ®Google Scholar
• TakedaKStaggJYagitaHOkumuraKSmythMJTargeting death-inducing receptors in cancer therapyOncogene200726253745375717530027
   PubMedGoogle Scholar
• WuYGuoEYuJXieQHigh DcR3 expression predicts stage pN2-3 in gastric cancerAm J Clin Oncol2008311798318376232
   PubMed Web of Science ®Google Scholar
• WuQZhengYChenDLiXLuCZhangZAberrant expression of decoy receptor 3 in human breast cancer: relevance to lymphangiogenesisJ Surg Res2014188245946524612949
   PubMed Web of Science ®Google Scholar
• JiangYQZhongTFDangYWOverexpression and clinicopathological contribution of DcR3 in bladder urothelial carcinoma tissuesAsian Pac J Cancer Prev201415219137914225422191
   PubMedGoogle Scholar
• ChenCZhangCZhuangGDecoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) developmentCancer Invest2008261096597419093253
   PubMed Web of Science ®Google Scholar
• TongJAoRWangYChangBWangBYPrognostic and clinicopathological differences of DcR3 in gastrointestinal cancer: evidence from meta-analysisInt J Clin Exp Med2014793096310525356187
   PubMed Web of Science ®Google Scholar
• YuWXuYCTaoYDcR3 regulates the growth and metastatic potential of SW480 colon cancer cellsOncol Rep20133062741274824101127
   PubMed Web of Science ®Google Scholar
• PittiRMMarstersSALawrenceDAGenomic amplification of a decoy receptor for Fas ligand in lung and colon cancerNature199839667126997039872321
   PubMed Web of Science ®Google Scholar
• YouleRJStrasserAThe BCL-2 protein family: opposing activities that mediate cell deathNat Rev Mol Cell Biol200891475918097445
   PubMed Web of Science ®Google Scholar
• Shamas-DinAKaleJLeberBAndrewsDWMechanisms of action of Bcl-2 family proteinsCold Spring Harb Perspect Biol201354a00871423545417
   PubMed Web of Science ®Google Scholar
• IndranIRTufoGPervaizSBrennerCRecent advances in apoptosis, mitochondria and drug resistance in cancer cellsBiochim Biophys Acta20111807673574521453675
   PubMed Web of Science ®Google Scholar
• LeBlancHLawrenceDVarfolomeevETumor-cell resistance to death receptor – induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog BaxNat Med20028327428111875499
   PubMed Web of Science ®Google Scholar
• HinzSTrauzoldABoenickeLBcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosisOncogene200019485477548611114725
   PubMed Web of Science ®Google Scholar
• ZhangLFangBMechanisms of resistance to TRAIL-induced apoptosis in cancerCancer Gene Ther200512322823715550937
   PubMed Web of Science ®Google Scholar
• NgCPZismanABonavidaBSynergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistanceProstate200253428629912430140
   PubMedGoogle Scholar
• JungYHLimEJHeoJKwonTKKimYHTunicamycin sensitizes human prostate cells to TRAIL-induced apoptosis by upregulation of TRAIL receptors and downregulation of cIAP2Int J Oncol20124061941194822426894
   PubMedGoogle Scholar
• HanZLeeSJeSSurvivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cellsApoptosis201621335136426677013
   PubMedGoogle Scholar
• FesikSWPromoting apoptosis as a strategy for cancer drug discoveryNat Rev Cancer200551187688516239906
   PubMed Web of Science ®Google Scholar
• MoffittKLMartinSLWalkerBFrom sentencing to execution – the processes of apoptosisJ Pharm Pharmacol201062554756220609056
   PubMedGoogle Scholar
• BodmerJLHollerNReynardSTRAIL receptor-2 signals apoptosis through FADD and caspase-8Nat Cell Biol20002424124310783243
   PubMed Web of Science ®Google Scholar
• SeolDWLiJSeolMHParkSYTalanianRVBilliarTRSignaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosisCancer Res20016131138114311221844
   PubMedGoogle Scholar
• ZhangYZhangBTRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5Mol Cancer Res20086121861187119074831
   PubMed Web of Science ®Google Scholar
• GuptaSCReuterSPhromnoiKNimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species- and ERK-dependent up-regulation of death receptors, p53, and BaxJ Biol Chem201128621134114621078664
   PubMedGoogle Scholar
• WeissingerDTagschererKEMacher-GoppingerSHaferkampAWagenerNRothWThe soluble Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and promotes migration and invasion in renal cell carcinomaMol Cancer201312112024107265
   PubMed Web of Science ®Google Scholar
• YoshidaTSakaiTPromoter of TRAIL-R2 geneVitam Horm200467354915110170
   PubMed Web of Science ®Google Scholar
• YouRIChangYCChenPMApoptosis of dendritic cells induced by decoy receptor 3 (DcR3)Blood200811131480148818006694
   PubMedGoogle Scholar